Lv11
30 积分 2026-02-27 加入
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
7小时前
求助中
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
9小时前
已完结
Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008
10小时前
已完结
Systemic treatment of patients with early breast cancer: recent updates and state of the art
13小时前
已完结
Immunotherapy in triple-negative breast cancer: From molecular mechanisms to precision medicine—overcoming resistance and optimizing clinical outcomes
3个月前
已关闭
皖公网安备34019202002308
